Vyvanse
lisdextroamfetamine, lisdextroamphetamine, lisdexamphetamine, lisdexamfetamine
Stimulant, Habit-forming, Common
Also known as lisdexamphetamine, the drug is a CNS stimulant often prescribed for ADHD, narcolepsy, and obesity. It is a pro-drug for dextroamphetamine, and functions as a method for providing extended-release stimulation. The drug is sometimes medically prescribed alongside an SSRI for depression.
Note:
Chart shows bounded mass ranges in mg. See the table for all doses.
Light
Common
Strong
Oral
20-30mg
30-50mg
50-100mg+
Onset
Duration
After Effects
Oral
1 to 1h 30m
6 to 14
1 to 16
Increased alertness, Euphoria, Increased motivation, Reduced appetite, Flushing of the face, Increased body temperature, Tachycardia (increased heart rate), Paranoia, Insomnia
Use of naltrexone has been found to successfully aid in recovery from amphetamine addiction - http://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.2008.08020304Vyvanse is approved for and proven to be affective for the treatment of binge-eating disorder in adults - http://onlinelibrary.wiley.com/doi/10.1111/ijcp.12639/fullVyvanse has been proven to be effectivein treating attention deficits in patients with traumatic brain injuries - http://www.tandfonline.com/doi/abs/10.3109/02699052.2014.930179For serotonin syndrome secondary to vyvanse overdose, dexmedetomidine may be used for treatment when standard treatment protocols do not work - http://aop.sagepub.com/content/48/12/1651.abstractVyvanse when used intravenously was proven to not have increased abuse liability, which implies that it does not have increased euphoria - http://jop.sagepub.com/content/early/2008/07/17/0269881108093841.shortthe drug is reported to be delayed by one additional hour when taken with a high fat meal - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873712/